Skip to content

Solid Biosciences Inc Sustainability Reports

Solid Biosciences Inc. is a life sciences company focused on developing gene therapies and transformative treatments for patients with neuromuscular and cardiac diseases, specifically Duchenne muscular dystrophy.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

FIGI: BBG00JN4FXH7

6 reports from 2017 to 2024